Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Abstract Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was t...

Full description

Bibliographic Details
Main Authors: Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Research Notes
Subjects:
SARS-CoV2
COVID-19
Convalescent plasma
Oxygen therapy
Desaturation
Online Access:https://doi.org/10.1186/s13104-021-05847-7

Internet

https://doi.org/10.1186/s13104-021-05847-7

Similar Items